Hanjing Xie

Pharmacogenetics of cyclophosphamide in patients with hematological malignancies

Hanjing Xie, Laimonas Griškevičius, Lars Ståhle et al. · European Journal of Pharmaceutical Sciences · 2005 · 101 citations

Hematological Malignancy, Medicine, Malignant Blood Disorder +6

A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment

Maria Browall, Yvonne Brandberg, Salmir Nasic et al. · Supportive Care in Cancer · 2016 · 61 citations · Full text

Nursing, Breast Oncology, Medicine +6

Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer

Dhifaf Sarhan, Caroline Leijonhufvud, Shannon Murray et al. · OncoImmunology · 2017 · 28 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +23

CYP2D6 and Adjuvant Tamoxifen: Possible Differences of Outcome in Pre- and Post-Menopausal Patients

Sara Margolin, Jonatan D. Lindh, L Thorén et al. · Pharmacogenomics · 2013 · 25 citations

Effect of cyclophosphamide on gene expression of cytochromes P450 and β-actin in the HL-60 cell line

Hanjing Xie, Stefan Lundgren, Ulrika Broberg et al. · European Journal of Pharmacology · 2002 · 21 citations

Molecular Pharmacology, Biochemistry, Medicine +13